KRISTI OTT: Open Payments
NPI 1184743650 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,387 in 106 payments from 15 companies in 2025. Trend: 2023 $1,650 · 2024 $2,269 · 2025 $2,387
Food & beverage: $2,387
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $715 |
| Janssen Biotech, Inc. | 12 | $345 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $317 |
| Lilly USA, LLC | 9 | $234 |
| Ardelyx, Inc. | 7 | $193 |
| Phathom Pharmaceuticals, Inc. | 7 | $138 |
| Aimmune Therapeutics, Inc. | 4 | $100 |
| Regeneron Healthcare Solutions, Inc. | 3 | $95 |
| GENZYME CORPORATION | 2 | $53 |
| PFIZER INC. | 2 | $47 |
Products named: TREMFYA, ENTYVIO, SKYRIZI, RINVOQ, OMVOH, IBSRELA, LINZESS, DUPIXENT.
Industry payments across MO — which companies pay providers there.
